Immunic, Inc. (IMUX) will implement a 1-for-10 reverse stock split of its outstanding common shares, effective April 27, 2026.
The reverse split aims to help the company meet obligations under a securities purchase agreement signed with institutional and accredited investors on February 12, 2026.
In premarket trading, IMUX shares dropped 4.42% to $0.8602.
Rolls-Royce has significantly upgraded its full-year financial outlook, driven by robust first-half profits fueled by increased defense spending and a…
High-end bars in London have pushed pint prices beyond the £10 barrier for the first time, signaling a sharp rise…
The Producer Price Index (PPI) indicates that wholesale inflation for final demand rose by 0.5% in December. This increase outpaced…
The U.S. manufacturing sector experienced a slowdown in growth during June, marking the eleventh consecutive month of expansion but at…
